(Q47981933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

False positivity in HER2 testing of breast cancer: novel paths for approaching an old dilemma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Cristiana Buzelin Nunes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Rafael Malagoli Rocha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Marcelo Araújo Buzelin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Débora Balabram

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Fernanda de Souza Foureaux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Simone Souza Porto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

18 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Pathology

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

946-950

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867547%20AND%20SRC:MED&resulttype=core&format=json

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

HER2 testing in the UK: further update to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Standardization of HER2 testing: results of an international proficiency-testing ring study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Systematic review of HER2 breast cancer testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

ASCO-CAP guidelines for breast predictive factor testing: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Evaluation of reliability of FISH versus brightfield dual-probe in situ hybridization (BDISH) for frontline assessment of HER2 status in breast cancer samples in a community setting: influence of poor tissue preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Validation of tissue microarray technology in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647

Selecting Antibodies to Detect HER2 Overexpression by Immunohistochemistry in Invasive Mammary Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201647